Pub. Date : 2014 Apr 1
PMID : 24470511
3 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Phase Ib study of Buparlisib plus Trastuzumab in patients with HER2-positive advanced or metastatic breast cancer that has progressed on Trastuzumab-based therapy. | NVP-BKM120 | erb-b2 receptor tyrosine kinase 2 | Homo sapiens |
| 2 | The purpose of this study was to determine the clinical activity of the PI3K inhibitor buparlisib (BKM120) in patients with HER2(+) advanced/metastatic breast cancer resistant to trastuzumab-based therapy. | NVP-BKM120 | erb-b2 receptor tyrosine kinase 2 | Homo sapiens |
| 3 | The purpose of this study was to determine the clinical activity of the PI3K inhibitor buparlisib (BKM120) in patients with HER2(+) advanced/metastatic breast cancer resistant to trastuzumab-based therapy. | NVP-BKM120 | erb-b2 receptor tyrosine kinase 2 | Homo sapiens |